Abstract
To study cognitive functions in 50–80 year aged type 2 diabetic patients. Cognitive performance was evaluated through a mini mental test (MMT) in 131 patients between 50 and 80 years (100 type 2 diabetics and 31 non-diabetics). Relation analysis were carried out for different parameters. Scores in registration and recall were significantly lower in diabetic group. The effect of HbA1c, body mass index (BMI) and age variables on MMT score was statistically significant. A negative linear correlation was estimated between MMT score and age, HbA1c level and BMI value. HbA1c, age and BMI were inversely related to cognitive functions. MMT scores were 24.98 ± 3.10 in diabetic group and 25.35 ± 3.22 in control group and statistically no significant difference was found. No significant difference was between type 2 diabetics and non-diabetics in terms of cognitive functions. But performance of diabetic patients in relation to the registration and recall was lower. Poor glycemic control and obesity in diabetics negatively affect cognitive performance.
Similar content being viewed by others
References
Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ. Joslin’s diabetes Mellitus. 14th ed. Lippincott Willams-Wilkins; 2005.
Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol. 2004;26:1044–80.
Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med. 1999;16:93–112.
Xu WL, Qui CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology. 2004;63:1181–6.
Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002;288:1475–83.
Tariot PN, Mack JL, Patterson MB, et al. The behavior rating scale for dementia of the consortium to establish a registry for Alzheimer’s disease. The behavioral pathology committee of the consortium to establish a registry for Alzheimer’s disease. Am J Psychiatry. 1995;152:1349–57.
Folstein MF, Folstein S, Mc Hugh PR. “Mini mental state” a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
Güngen C, Ertan T, Eker E, et al. Standardize mini mental test’in Türk Toplumunda Hafif Demans Tanısında Geçerlik ve Güvenilirliği. Türk Psikiyatri Dergisi. 2002;13:273–81.
Wahlin A, Nilsson E, Fastbom J. Cognitive performance in very old diabetic persons: the impact of semantic structure, preclinical dementia, and impending death. Neuropsychology. 2000;16:208–16.
Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 1999;53:1937–42.
Hassing LB, Johansson B, Nilsson SE, Berg S, Pedersen NL, Gatz M, et al. Diabetes mellitus is a risk factor for vasculare dementia, but not for Alzheimer’s disease: a population-based study of the oldest old. İnt Psychogeriatr. 2002;14:77–83.
Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64–74.
Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277–81.
Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Haris T, Shorr Rİ, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. LAMA. 2004;292:2237–42.
Kernan WN, İnzucchi SE, Viscoli CM, Brass LM, Bravata DM, Horwitz Rİ. İnsulin resistance and risk of stroke. Neurology. 2002;59:809–15.
Launer LJ. Diabetes and brain aging: epidemiologic evidence. Curr Diab Rep. 2005;5:59–63.
Alex M, Baron EK, Goldenberg S, et al. An autopsy of cerebrovascular accident in diabetes mellitus. Circulation. 1962;25:663–73.
Biessels GJ, Koffeman A, Scheltens P. Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic. J Neurol. 2006;253:477–82.
Biessels GJ, Kamal A, Ramakers GM, Urban İJ, Spruijt BM, Erkelens DW, et al. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes. 1996;45:1259–66.
Smith MA, Sayre LM, Monnier VM, Perry G. Radical Ageing in Alzheimer’s disease. Trends Neurosci. 1995;18:172–6.
Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology. 2004;63:658–63.
Vanhanen M, Koivisto K, Kuusisto J, Mykkanen L, Helkala EL, Hanninen T, et al. Cognitive fonction in an elderly population with persistent impaired glucose tolerance. Diabetes Care. 1998;21:398–402.
Xu W, Qui C, Winblad B, Fratiglioni L. The effect of borderline diabetes on the risk of dementia and Alzheimer’s disease. Diabetes. 2007;56:211–6.
van den Berg E et al. Cognitive fonctioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study. Dement Geriatr Cogn Disord. 2008;26:261–9.
Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, et al. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care. 2007;30:2655–60.
Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol. 2000;20:2255–60.
Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Lunchsinger JA. Metabolic syndrome and dementia risk in multiethnic elderly cohort. Dement Geriatr Cogn Disord. 2007;24:185–92.
Peila R, Rodriguez BL, White LR, Launer LJ. Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology. 2004;63:228–33.
Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I, et al. Metabolic syndrome and cognitive function: a population – based follow-up study in elderly women. Dement Geriatr Cogn Disord. 2007;23:29–34.
Xiong GL, Plassman BL, Helms MJ, Steffens DC. Vascular risk factors and cognitive decline among elderly male twins. Neurology. 2006;67:1586–91.
Yaffe K. Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord. 2007;21:167–71.
Brands AM, Biessels GJ, De Haan EH, Kappelle LJ, Kessels RP. The effects of type 1 diabetes on cognitive performance: a meta analysis. Diabetes Care. 2005;28:726–35.
Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med. 2007;356:1842–52.
Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu –Asia aging study. Diabetes. 2002;51:1256–62.
Yaffe K, Blackwell T, Whitmer RA, Krueger K, Baret CE. Glycosylated hemoglobin level and development of mild cognitive impairment or demetia in older women. J Nutr Health Aging. 2006;10:293–5.
Yaffe K, Blackwell T, Whitmer RA, et al. Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging. 2006;10:293–5.
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Temizel, M., Mert, M., Yanar, H. et al. Evaluation of cognitive functions and the related factors in 50–80 year type 2 diabetic subjects. Int J Diabetes Dev Ctries 33, 71–74 (2013). https://doi.org/10.1007/s13410-013-0126-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-013-0126-2